(Q34643604)

3 August 2017

RIP1 expression is necessary for CD30-mediated cell death induction in anaplastic large-cell lymphoma cells (English)

1 reference

anaplastic large-cell lymphoma

3 August 2017

1 reference

1 reference

1 reference

3

Michael Hummel

1 reference

3 August 2017

Burkhard Hirsch

1

1 reference

3 August 2017

Edda von der Wall

series ordinal

2

1 reference

3 August 2017

Horst Dürkop

series ordinal

4

1 reference

3 August 2017

1 April 2013

1 reference

3 August 2017

Laboratory Investigation

1 reference

3 August 2017

93

1 reference

3 August 2017

6

1 reference

3 August 2017

677-689

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.2013.50

3 August 2017

0 references

cites work

Antibody-drug conjugates in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

CD30-mediated cell cycle arrest associated with induced expression of p21(CIP1/WAF1) in the anaplastic large cell lymphoma cell line Karpas 299.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

The fully human anti-CD30 antibody 5F11 activates NF-{kappa}B and sensitizes lymphoma cells to bortezomib-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

RIP1, a kinase on the crossroads of a cell's decision to live or die

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

The death domain kinase RIP1 links the immunoregulatory CD40 receptor to apoptotic signaling in carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

21 January 2018

IAPs: guardians of RIPK1

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

CD95 stimulation results in the formation of a novel death effector domain protein-containing complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

Molecular mechanisms of necroptosis: an ordered cellular explosion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

The Ripoptosome: death decision in the cytosol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

Necroptosis as an alternative form of programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

The molecular regulation of programmed necrotic cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

Identification of RIP1 kinase as a specific cellular target of necrostatins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

RIP kinases at the crossroads of cell death and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

A novel A20 (TNFAIP3) antibody (Ber-A20) can be used to detect unmutated A20 by immunohistology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

cIAP2 is highly expressed in Hodgkin-Reed-Sternberg cells and inhibits apoptosis by interfering with constitutively active caspase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

CD30-induced up-regulation of the inhibitor of apoptosis genes cIAP1 and cIAP2 in anaplastic large cell lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

Two distinct signalling cascades target the NF-kappaB regulatory factor c-IAP1 for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

Death receptors: targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

Hsp90 molecular chaperone inhibitors: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

RIPK1 is not essential for TNFR1-induced activation of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

(Un)expected roles of c-IAPs in apoptotic and NFkappaB signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

TNFR1-induced activation of the classical NF-κB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

Linear ubiquitination prevents inflammation and regulates immune signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

CD30-targeted antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

Large anaplastic cell Ki-1 positive malignant lymphoma with peculiar endocytotic vacuoles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

The roles of flotillin microdomains--endocytosis and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.50

10.1038/LABINVEST.2013.50

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference